Research Library
Immune & Neural Research

KPV: Research Evidence, Safety Signals and Evidence Limitations

Also referenced as: Lys-Pro-Val, α-MSH (11-13)

Preclinical data Lot-tested COA verifiedResearch use only

A literature-led overview of KPV — what has actually been measured in the published record, what remains unknown, and how research-grade material is characterised.

4 min read · Literature review · Updated 2026

Research-grade KPV vials — lot-matched certificate of analysis on request, from $31.99.

Shop KPV

What KPV is

The C-terminal tripeptide of α-MSH, investigated in inflammatory-pathway and mucosal research models.

KPV is supplied as a research peptide in lyophilised form for laboratory research. The published record is dominated by preclinical sources, which is the most important caveat when reading any summary of reported findings.

KPV research evidence

The areas below summarise what published work has actually measured. Each is an observation reported in the cited literature — not a claimed outcome, and not a statement of efficacy in humans.

  • Inflammatory pathway research

    Cell and rodent models have investigated NF-κB-associated signalling endpoints.

How it is described mechanistically

Mechanistic descriptions of KPV in the literature centre on the pathways below. Pathway attributions should be read as proposed rather than settled.

  • NF-κB pathway modulation

    In-vitro literature describes reduced NF-κB nuclear translocation in stimulated cell models. Pathway noted in the literature: NF-κB signalling.

KPV safety signals and evidence limitations

No controlled human safety data identified.

No consistent adverse-event profile has been established for KPV. The meaningful limitation is absence of data rather than a documented list of effects.

Open data gaps: human trials. Peptide Lounge does not publish dosing or administration guidance for any compound, and this material is not for human or veterinary use.

Analytical documentation and laboratory handling

Analytical values for KPV are lot-specific. Rather than publishing a universal figure, Peptide Lounge provides the lot-matched certificate of analysis for the batch you received on request, so the reported result corresponds to the material in hand.

Vials ship lyophilised and sealed. Store unopened vials according to the handling information supplied with the material and applicable literature. Solution preparation should use a solvent or buffer validated for the intended analytical method and material; consult applicable literature and lot-specific documentation. Peptide Lounge does not publish preparation, concentration or administration guidance.

How researchers source KPV

KPV is stocked as a 10mg single-compound vial, with volume pricing applied automatically to multi-vial orders. Free bacteriostatic water and research supplies are included on qualifying orders.

Related research vials

KPV — frequently asked questions

What does published research report about KPV?

Published work describes inflammatory pathway research. The work summarised here is preclinical or in-vitro; Peptide Lounge does not summarise trial-level human evidence for this material.

What safety signals have been reported for KPV?

No established adverse-event profile exists. The substantive limitation is missing data: human trials.

Is KPV approved for human use?

No. KPV supplied by Peptide Lounge is a laboratory reagent for in-vitro and laboratory research only. It is not an approved drug and is not for human or veterinary use.

How is KPV supplied and handled?

KPV is supplied as a sealed lyophilised vial. Storage and solution preparation should follow the applicable literature and a solvent or buffer validated for the intended analytical method and material. Peptide Lounge does not publish preparation or administration guidance.

How do I verify the analytical results for a KPV vial?

Request the lot-matched certificate of analysis for the batch you received. Reported results are specific to that lot rather than a generic sample document.

Research areas

Inflammatory pathway research

Preclinical data

Cell and rodent models have investigated NF-κB-associated signalling endpoints.

Mechanisms of action (as described in literature)

NF-κB pathway modulation

In vitro data

In-vitro literature describes reduced NF-κB nuclear translocation in stimulated cell models.

NF-κB signalling

Published studies

No peer-reviewed study links are curated for this compound yet. Available information is limited to analytical and preclinical sources. Absence of linked studies should be read as an evidence gap.

Safety signals & data gaps

Reported signals only — safety is not established

No controlled human safety data identified.

Known data gaps: Human trials.

For Research Use Only

All products listed are supplied strictly as laboratory reagents for in-vitro research and analytical work conducted by qualified professionals. They are not drugs, foods, cosmetics or medical devices, and must not be administered to humans or animals. No product on this site is approved by the FDA for human use.

Research Use Only: Products are sold strictly for laboratory research and educational purposes only. Not for human consumption, veterinary use, food use, cosmetic use, or therapeutic application. Products are not intended to diagnose, treat, cure, or prevent any disease.